Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spoon size influences misdosing of liquid OTCs

This article was originally published in The Tan Sheet

Executive Summary

A study that found participants misdose liquid cold medicine depending on the size of the spoon they use supports FDA's and industry's push to standardize measurements and dosing devices. A study by Brian Wansink and Koert van Ittersum at Cornell University in the Jan. 5 Annals of Internal Medicine found consumers who use a medium-sized spoon to measure liquid cold medicine poured an average 8.4 percent less than the prescribed amount, but 11.6 percent more with a larger spoon. They asked 195 university students to pour 1 teaspoon of cold medicine in a measuring spoon and then pour 1 teaspoon in a medium spoon and a large spoon and rate how confident they were that they poured the correct amount. Participants had an above-average confidence they accurately poured the amount. While the difference may seem minimal, "the dosing error is likely to accumulate among fatigued patients who are medicating themselves every four to eight hours for several days," the researchers say. The risk of misdosing liquid medicines with the wrong measuring device prompted FDA to recommend in recent guidance that firms "secure the dosage delivery device to the drug product" (1"The Tan Sheet" Nov. 9, 2009). The agency notes in its Safe Use Initiative that misdosing liquid OTC products is worrisome because children often use them. The Consumer Healthcare Products Association also recommends standardized labeling of OTC oral liquids to prevent misdosing (2"The Tan Sheet" Dec. 7, 2009)

You may also be interested in...



CHPA Adopts Dosing Guidelines For OTC Pediatric Liquids

The Consumer Healthcare Products Association recommends a standardized labeling format for OTC pediatric oral liquids to help prevent accidental overdoses and misdosing

FDA Gets Strict On Liquid OTC Dosing Devices In Draft Guidance

Some drug firms may need to alter their product packaging and labeling to comply with FDA's guidance on dosing device labeling for liquid OTCs

Lilly Looks To Accelerate Tirzepatide Into Obesity With Rolling Submission

Plan for rolling submission means US FDA filing of GIP/GLP1 agonist in obesity could be complete by April 2023, setting up possibility of late 2023 approval.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS103693

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel